The post involves collation and/or collection of clinical data, transcription of clinical trial data into trial specific databases, communication with the study team and study sponsors, developing tools to support protocol specific data-capturing, maintaining study specific files, archive the studies, work with team for study audits, and support study team in meeting data locks. The role requires familiarity with medical terminology and a comprehensive approach to processing trial data and also ability to work under pressure.
Key Requirements
Applications are invited from candidates with a health/science related higher education qualification or relevant experience in clinical trials, who possess excellent organisational skills, strong interpersonal and communication skills and high level of time management skills. The successful candidate will be computer literate and will preferably have previous experience in oncology or clinical trial research or extensive experience in healthcare administration.
Appointments will be on a one-year contract in the first instance. To apply for this post, please submit an online application including a supporting statement, detailing reasons why you are applying for the post and with your CV. We encourage all applicants to access the job pack attached for more detailed information regarding this role.
Due to the high volumes of applications we receive, we reserve the right to close the advert before the published closing date once we have received a sufficient number of applications. Therefore we advise that you to submit your application, as early as possible to avoid disappointment.
Department/Directorate Information
The Drug Development Unit, within the ICR and Royal Marsden, is a dedicated Clinical Trials Unit, with bespoke facilities to conduct early phase clinical trials.
The Unit, led by Professor Johann de Bono, comprises of clinicians, scientists, data and study management staff, and focuses on providing a seamless conduit between pre-clinical drug discovery, proof of principle Phase-1 clinical trials and tumour specific evaluation of novel agents. The Unit undertakes both industry-sponsored and investigator-initiated trials of new anti-cancer drugs. The Unit is rapidly expanding and provides an excellent opportunity for the post holder to develop a variety of skillsets.